Leap therapeutics' board of directors member dr. monica bertagnolli appointed as the director of the national cancer institute

Dr. bertagnolli to transition off leap's board of directors cambridge, mass. , aug. 12, 2022 /prnewswire/ -- leap therapeutics, inc. (nasdaq:lptx), a biotechnology company focused on developing targeted and immuno-oncology therapeutics today announced that its board member, monica bertagnolli, md, has been appointed as the 16th director of the national cancer institute (nci) by the biden administration.
LPTX Ratings Summary
LPTX Quant Ranking